EDTA‐induced pseudothrombocytopenia in hematopoietic stem cell donor

Abstract

We herein report a case of peripheral blood stem cell transplantation (PBSCT) involving a donor with EDTA‐induced pseudothrombocytopenia (PTCP). The apheresis product was inspected for 24 h and there was no platelet clumping or thrombocytopenia. In the first 14 months after PBSCT, there has been no transfer of PTCP symptoms.In our case, pseudothrombocytopenia (PTCP) symptoms were not transferred from a stem cell donor to the recipient, and the apheresis products harvested with appropriate anticoagulants did not exhibit PTCP. Peripheral blood stem cell transplantation involving PTCP donors may be managed identically to that involving non‐PTCP donors.